THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Boston Scientific dealt stent setback

Jury finds Natick firm infringed J&J's rights to 2 patents on devices

By Ross Kerber
Globe Staff / June 22, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A US District Court jury in Delaware yesterday found that Boston Scientific Corp. infringed two cardiac stent patents, a setback that could force the Natick medical-devices maker to pay more than $1 billion in damages to its chief competitor, Johnson & Johnson . The amount will be set in August at a separate trial, but the company said it will ... (Full article: 573 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass